Invention Grant
US08546581B2 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
有权
用于口服递送胰高血糖素样肽（Glp）-1化合物或黑皮质素-4受体（Mc4）激动剂肽的化合物，方法和制剂
- Patent Title: Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
- Patent Title (中): 用于口服递送胰高血糖素样肽（Glp）-1化合物或黑皮质素-4受体（Mc4）激动剂肽的化合物，方法和制剂
-
Application No.: US13087255Application Date: 2011-04-14
-
Publication No.: US08546581B2Publication Date: 2013-10-01
- Inventor: Louis Nickolaus Jungheim , John Mcneill McGill, III , Kenneth Jeff Thrasher , Robert Jason Herr , Muralikrishna Valluri
- Applicant: Louis Nickolaus Jungheim , John Mcneill McGill, III , Kenneth Jeff Thrasher , Robert Jason Herr , Muralikrishna Valluri
- Applicant Address: US NJ Roseland
- Assignee: Emisphere Technologies, Inc.
- Current Assignee: Emisphere Technologies, Inc.
- Current Assignee Address: US NJ Roseland
- Agency: Blank Rome LLP
- Main IPC: C07D271/06
- IPC: C07D271/06 ; C07D401/00 ; C07D409/00
Abstract:
The present application relates to novel compounds, methods and formulations useful for the oral delivery of a glucagon like peptide-1 compound or a melanocortin 4 receptor agonist peptide.
Public/Granted literature
Information query
